Biosortia Pharmaceuticals

Description

• Biosortia Finds New Medicines-Biosortia Pharmaceuticals is the only company directly bringing the deep dark chemistry of any microbiome into drug discovery with the most sought after drug-like molecules that are generally unobtainable to researchers. Biosortia is digging into actual unknown microbiome chemistry at 100,000 to 1,000,000 times deeper than science has typically explored. We have proprietary technologies and capabilities to rapidly fill a discovery pipeline with high priority unmet needs in key therapeutic areas. There is an unfilled continuous need by Pharma and investment groups to find and exploit IND stage assets. Biosortia Pharmaceuticals is focused on early stage drug discovery to generally an IND stage exit for risk share licensing to pharma or spinning-out into a new company.This is the most exciting breakthrough in access to new meaningful natural product chemistry for drugs, potentially opening the 99% of unculturable microorganisms in situ to discovery. As a reference; the 1% of culturable microorganisms have led directly or indirectly to more the 25% of the drugs on the market today.Our Vision is to improve human health with our new valuable chemistry!What is a microbiome?Simply put it is the microbial community occupying a reasonably well-defined habitat which has distinct Physico-chemical properties. The term thus not only refers to the microorganisms involved but also encompasses their theaters of activity. *The term was first used in 2000 and in print 2001..
• 

  Headquarters:4266 Tuller Road , Dublin, Ohio, United States

  More
• 

  Phone Number: +1 614-636-4850

• 

  Website: https://www.biosortia.com

• 

  Employees:8

• 

  Revenue:$1 - 10M

• 

  Legal Name:Biosortia Pharmaceuticals

• Biosortia Pharmaceuticals's Social Media

  
• Is this data correct?

• |  NAICS Code: 424210  |

  Show More